Related Experiment Video
Updated: Aug 24, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
A Commentary on the NIH Consensus Development Statement 'Genetic Testing for Cystic Fibrosis'
1Institute of Human Genetics, Hannover Medical School, Hannover, Germany. schmidtke.joerg@mh-hannover.de
Abstract:
A NIH Consensus Development Statement recommends implementation of a cystic fibrosis carrier screening in the general pregnant and pre-pregnant population. This suggestion is discussed in the light of missing or insufficient data about the reasons for high uptake rates in pilot projects, psychological and social risks, and optimal educational and counselling settings. It is concluded that the recommendation is not defendable and, at best, premature.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pharmacogenomics: Identification of New Drug Targets
Animal Mitochondrial Genetics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

